Wednesday, August 26, 2020 7:10:21 PM
"Approval of the proxy proposals should give us time we need to secure new investment dollars, allowing us to stabilize the Company financially and to move forward to the point of a true market valuation based on our MMJ products and IP."
What MMJ products? A drug patent that hasn't started FDA approved clinical trials has very little value - so much for the IP.
OWCP only has access to toxic financing - how is more toxic funding going to stabilize the company financially?
This isn't explaining the need for a reverse split.
IG
"Are you gonna pull those pistols or whistle Dixie?"
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM